An open label randomized clinical trial of Indomethacin for mild and moderate hospitalised Covid-19 patients.
Sci Rep. 2022 Apr 19;12(1):6413. doi: 10.1038/s41598-022-10370-1.
Sci Rep. 2022.
PMID: 35440611
Free PMC article.
Clinical Trial.